Harvard Apparatus Regenerative Technology Net Profit Margin 2013-2024 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Harvard Apparatus Regenerative Technology net profit margin from 2013 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Harvard Apparatus Regenerative Technology Net Profit Margin 2013-2024 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Harvard Apparatus Regenerative Technology net profit margin from 2013 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$99.6B
Cencora (COR)	$48.8B
DiDi Global (DIDIY)	$24.4B
ICON (ICLR)	$17.7B
Natera (NTRA)	$16.1B
Viatris (VTRS)	$15.7B
Avantor (AVTR)	$15.6B
Revvity (RVTY)	$15.1B
BioMerieux (BMXMF)	$13.1B
Solventum (SOLV)	$13B
CochLear (CHEOY)	$12.8B
Medpace Holdings (MEDP)	$11B
Charles River Laboratories (CRL)	$10.8B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.5B
Doximity (DOCS)	$8.1B
Bausch + Lomb (BLCO)	$7.1B
Life Times (LTH)	$5.1B
Sotera Health (SHC)	$4.5B
Organon (OGN)	$4.2B
Surgery Partners (SGRY)	$3.9B
BrightSpring Health Services (BTSG)	$3.3B
PACS (PACS)	$3B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.6B
Ardent Health Partners (ARDT)	$2.5B
Premier (PINC)	$2.3B
GeneDx Holdings (WGS)	$2.1B
Ryman Healthcare (RYHTY)	$2B
GoodRx Holdings (GDRX)	$1.9B